How many patents does
Array Biopharma have?
patents
3,187
families
196
granted
745
applications
2,442
US
518
EP
279
CN
211
JP
141
WO
131
KR
101
RoW
1,806
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Array Biopharma
Top ten assignees appearing on patents
2009 - 2018
| array biopharma | 2597 |
| genentech | 466 |
| astrazeneca | 150 |
| intermune | 112 |
| ventirx pharmaceuticals | 109 |
| novartis | 91 |
| irm | 43 |
| roche | 27 |
| amgen | 15 |
| loxo oncology | 13 |
2009
| array biopharma | 231 |
| genentech | 49 |
| intermune | 32 |
| astrazeneca | 13 |
| amgen | 3 |
| brad newhouse | 3 |
| ehrrej bajofarma ink. | 1 |
| ehrrehj biofarma | 1 |
| gentech | 1 |
| ehrrehj biofarma ink. | 1 |
2018
| array biopharma | 201 |
| genentech | 35 |
| loxo oncology | 11 |
| ventirx pharmaceuticals | 4 |
| astrazeneca | 3 |
| mirati therapeutics | 3 |
| celgene corporation | 2 |
| novartis | 1 |
| roche | 1 |
Array Biopharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| n3 alkylated benzimidazole derivatives as mek inhibitors | 98 | 2002 |
| substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors | 93 | 2008 |
| heterocyclic inhibitors of mek and methods of use thereof | 87 | 2003 |
| compounds and compositions as protein kinase inhibitors | 79 | 2009 |
| p38 inhibitors and methods of use thereof | 79 | 2003 |
| hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors | 77 | 2006 |
| macrocyclic compounds as trk kinase inhibitors | 72 | 2010 |
| heterocyclic inhibitors of mek and methods of use thereof | 70 | 2005 |
| 6-substituted phenoxychroman carboxylic acid derivatives | 59 | 2008 |
| serine/threonine kinase inhibitors | 56 | 2012 |